Related Experiment Video
Updated: Nov 1, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Association between Hb A1c and Severity of COVID-19 Patients
Goksenin Unluguzel Ustun1, Adem Keskin2, Recai Aci1
1Department of Biochemistry, University of Health Sciences, Samsun, Turkey.
Insights
High hemoglobin A1c (HbA1c) levels in COVID-19 patients are linked to increased inflammation, coagulation issues, and higher mortality rates. Monitoring HbA1c may improve risk assessment for severe COVID-19 outcomes.
Area of Science:
- Endocrinology
- Infectious Diseases
- Critical Care Medicine
Background:
- Diabetes, indicated by elevated hemoglobin A1c (HbA1c), is a known risk factor for severe infections.
- The clinical implications of varying HbA1c levels in coronavirus-19 (COVID-19) patients require further investigation.
- Understanding these associations can aid in predicting COVID-19 severity and patient outcomes.
Purpose of the Study:
- To investigate the relationship between HbA1c levels and the clinical course of COVID-19.
- To assess the impact of high HbA1c on intensive care unit (ICU) admission and mortality in COVID-19 patients.
- To identify correlations between HbA1c levels and key inflammatory and coagulation markers.
Main Methods:
- Retrospective analysis of 66 COVID-19 positive (COVID-19(+)) patients with high HbA1c, 46 COVID-19(+) patients with average HbA1c, and 30 COVID-19 negative patients.
- Comparison of clinical parameters including hemoglobin (Hb), oxygen saturation (SaO2), ferritin, D-dimer, procalcitonin (PCT), C-reactive protein (CRP), and lactate dehydrogenase (LDH) between groups.
- Correlation analysis between HbA1c levels and clinical parameters; Chi-squared test used for ICU admission and mortality analysis.
Main Results:
- COVID-19(+) groups exhibited lower Hb and SaO2, and higher ferritin, D-dimer, PCT, and CRP compared to controls.
- High HbA1c COVID-19(+) patients showed elevated LDH, PCT, and D-dimer, with lower Hb and partial arterial oxygen pressure (PaO2).
- HbA1c positively correlated with absolute neutrophil count (ANC), LDH, PCT, and potassium (K+); negatively correlated with Hb and PaO2. High HbA1c was associated with increased mortality.
Conclusions:
- Elevated HbA1c levels in COVID-19 patients are significantly associated with heightened inflammation, coagulation disturbances, and hypoxemia.
- High HbA1c is a predictor of increased mortality risk in COVID-19 patients.
- Integrating HbA1c measurements with other prognostic markers can enhance the assessment of mortality risk in COVID-19.
Abstract:
This study aimed to examine the relationship between Hb A1c levels and the clinical course of coronavirus-19 (COVID-19) patients. Sixty-six COVID-19(+) patients with high Hb A1c and 46 with average Hb A1c and 30 COVID-19(-) patients with average Hb A1c were included. Hb A1c levels and parameters examined in COVID-19(+) patients were compared between groups, and correlation analysis was performed between these parameters and Hb A1c levels. The effect of Hb A1c levels on intensive care unit (ICU) admission and mortality rate in COVID-19 patients was analyzed with the χ2 test. It was observed that hemoglobin (Hb) and arterial oxygen saturation (SaO2) levels of the COVID-19 (+) groups was lower than the COVID-19 (-) group, while ferritin, D-dimer, procalcitonin (PCT), and C-reactive protein (CRP) levels were higher. The COVID-19 (+) group with high Hb A1c had higher lactate dehydrogenase (LDH), PCT and D-dimer levels than the other two groups, while Hb, partial arterial oxygen pressure (PaO2) levels were lower. The Hb A1c levels of the COVID-19 (+) groups were positively correlated with absolute neutrophil count (ANC), LDH, PCT and (K+) levels, while negatively correlated with Hb and PaO2 levels. Hb A1c was found to be associated with the inflammation process, coagulation disorders and low PaO2 in COVID-19 patients. The COVID-19 patients with high Hb A1c levels had a higher mortality rate than other COVID-19 patients. Using Hb A1c measurements with other prognostic markers would contribute to the patient's risk of death assessment.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Related Concept Videos
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hazard Ratio
For example, in a clinical trial...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...